Trial intelligence / Profile preview

Indomethacin Dosing for PDA in Preterm Infants

NCT00187447Phase 2Completed

Sponsor
University of California, San Francisco
Start
Aug 2003
Primary completion
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indomethacin in patent ductus arteriosus (PDA), sponsored by University of California, San Francisco. Started Aug 2003; status: completed.

02

Drugs

indomethacin
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on NCT00187447.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00187447.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call